Importantly, expression of PD-1 and TIM-3 on CD8+ T cells, as well as on CD4+ T cells, were positively correlated to tumor volume on day 14 and supports the concept that sustained inhibitory receptor expression is associated with lack of antitumor activity. This evidence concerns the gene PDCD1 and neoplasm.